These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36438078)

  • 1. Editorial: Chemical testing using new approach methodologies (NAMs).
    Stucki AO; Clippinger AJ; Henry TR; Hirn C; Stedeford TJ; Terry C
    Front Toxicol; 2022; 4():1048900. PubMed ID: 36438078
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive Workshop.
    Westmoreland C; Bender HJ; Doe JE; Jacobs MN; Kass GEN; Madia F; Mahony C; Manou I; Maxwell G; Prieto P; Roggeband R; Sobanski T; Schütte K; Worth AP; Zvonar Z; Cronin MTD
    Regul Toxicol Pharmacol; 2022 Nov; 135():105261. PubMed ID: 36103951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing food safety risk assessment in China: development of new approach methodologies (NAMs).
    Yang D; Yang H; Shi M; Jia X; Sui H; Liu Z; Wu Y
    Front Toxicol; 2023; 5():1292373. PubMed ID: 38046399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating the Pace of Chemical Risk Assessment.
    Kavlock RJ; Bahadori T; Barton-Maclaren TS; Gwinn MR; Rasenberg M; Thomas RS
    Chem Res Toxicol; 2018 May; 31(5):287-290. PubMed ID: 29600706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health.
    Stucki AO; Barton-Maclaren TS; Bhuller Y; Henriquez JE; Henry TR; Hirn C; Miller-Holt J; Nagy EG; Perron MM; Ratzlaff DE; Stedeford TJ; Clippinger AJ
    Front Toxicol; 2022; 4():964553. PubMed ID: 36119357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).
    Andersen ME; McMullen PD; Phillips MB; Yoon M; Pendse SN; Clewell HJ; Hartman JK; Moreau M; Becker RA; Clewell RA
    ALTEX; 2019; 36(4):523-534. PubMed ID: 31664457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT-NAMs Symposium.
    Lee KM; Corley R; Jarabek AM; Kleinstreuer N; Paini A; Stucki AO; Bell S
    Toxics; 2022 Dec; 10(12):. PubMed ID: 36548593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of tobacco and other nicotine-containing products.
    Miller-Holt J; Behrsing HP; Clippinger AJ; Hirn C; Stedeford TJ; Stucki AO
    Front Toxicol; 2022; 4():943358. PubMed ID: 36157974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ideas for non-animal approaches to predict repeated-dose systemic toxicity: Report from an EPAA Blue Sky Workshop.
    Mahony C; Ashton RS; Birk B; Boobis AR; Cull T; Daston GP; Ewart L; Knudsen TB; Manou I; Maurer-Stroh S; Margiotta-Casaluci L; Müller BP; Nordlund P; Roberts RA; Steger-Hartmann T; Vandenbossche E; Viant MR; Vinken M; Whelan M; Zvonimir Z; Cronin MTD
    Regul Toxicol Pharmacol; 2020 Jul; 114():104668. PubMed ID: 32335207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs).
    Avila AM; Bebenek I; Bonzo JA; Bourcier T; Davis Bruno KL; Carlson DB; Dubinion J; Elayan I; Harrouk W; Lee SL; Mendrick DL; Merrill JC; Peretz J; Place E; Saulnier M; Wange RL; Yao J; Zhao D; Brown PC
    Regul Toxicol Pharmacol; 2020 Jul; 114():104662. PubMed ID: 32325112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting the Perception of New Approach Methodologies (NAMs) in the Ecotoxicology Community.
    Mondou M; Hickey GM; Rahman HT; Maguire S; Pain G; Crump D; Hecker M; Basu N
    Integr Environ Assess Manag; 2020 Mar; 16(2):269-281. PubMed ID: 31944596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brazil's Regulatory Context for Using New Approach Methodologies (NAMs) on the Registration of Products.
    Villela IV; Machado MDS
    Front Toxicol; 2022; 4():903027. PubMed ID: 35936389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RE-Place: A Unique Project Collecting Expertise on New Approach Methodologies.
    Van Mulders M; Liodo Missigba N; Mertens B; Rogiers V
    Front Pharmacol; 2022; 13():930148. PubMed ID: 35814243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ready for regulatory use: NAMs and NGRA for chemical safety assurance.
    Carmichael PL; Baltazar MT; Cable S; Cochrane S; Dent M; Li H; Middleton A; Muller I; Reynolds G; Westmoreland C; White A
    ALTEX; 2022; 39(3):359–366. PubMed ID: 35796331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment.
    Punt A; Bouwmeester H; Blaauboer BJ; Coecke S; Hakkert B; Hendriks DFG; Jennings P; Kramer NI; Neuhoff S; Masereeuw R; Paini A; Peijnenburg AACM; Rooseboom M; Shuler ML; Sorrell I; Spee B; Strikwold M; Van der Meer AD; Van der Zande M; Vinken M; Yang H; Bos PMJ; Heringa MB
    ALTEX; 2020; 37(4):607-622. PubMed ID: 32521035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.
    Nymark P; Bakker M; Dekkers S; Franken R; Fransman W; García-Bilbao A; Greco D; Gulumian M; Hadrup N; Halappanavar S; Hongisto V; Hougaard KS; Jensen KA; Kohonen P; Koivisto AJ; Dal Maso M; Oosterwijk T; Poikkimäki M; Rodriguez-Llopis I; Stierum R; Sørli JB; Grafström R
    Small; 2020 Feb; 16(6):e1904749. PubMed ID: 31913582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs).
    Irizar A; Bender H; Griem P; Natsch A; Vey M; Kimber I
    Regul Toxicol Pharmacol; 2022 Oct; 134():105244. PubMed ID: 35932886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework for chemical safety assessment incorporating new approach methodologies within REACH.
    Ball N; Bars R; Botham PA; Cuciureanu A; Cronin MTD; Doe JE; Dudzina T; Gant TW; Leist M; van Ravenzwaay B
    Arch Toxicol; 2022 Mar; 96(3):743-766. PubMed ID: 35103819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials.
    Petersen EJ; Ceger P; Allen DG; Coyle J; Derk R; Garcia-Reyero N; Gordon J; Kleinstreuer NC; Matheson J; McShan D; Nelson BC; Patri AK; Rice P; Rojanasakul L; Sasidharan A; Scarano L; Chang X
    ALTEX; 2022; 39(2):183–206. PubMed ID: 34874455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation framework for new approach methodologies (NAMs) for human health safety assessment.
    Parish ST; Aschner M; Casey W; Corvaro M; Embry MR; Fitzpatrick S; Kidd D; Kleinstreuer NC; Lima BS; Settivari RS; Wolf DC; Yamazaki D; Boobis A
    Regul Toxicol Pharmacol; 2020 Apr; 112():104592. PubMed ID: 32017962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.